Michael Muenzberg
Physician
Comparative Outcomes Group
Check out the incredible speaker line-up to see who will be joining Michael.
Download The Latest Agenda
Biosimilars Commercialisation Summit Agenda 2019
Speaker Spotlight- Michael Muenzberg, MD, on the good, the bad and the ugly of the biosimilars market
Conference Day One
Wednesday, February 5th, 2020
10:10 AM Panel Discussion: Exploring the Sensitivity and Complexity of the North American Biosimilars Market
- Overcome the current battle to combat misinformation surrounding biosimilars in the US, and the essential methods to boost stakeholder confidence, in the face of immense competition from biologics
- Discuss the current regulatory landscape with respect to the FDA Biosimilar Action Plan and the newly published regulatory framework regarding the use of real world evidence and real world data
- Explore the game-changing concept of the ‘Purple Book’ for pharmacists, asking “Does this make either medical or commercial logic?”
Conference Day Two
Thursday, March 5th, 2020
4:10 PM Fire-Side Chat: Objection Handling Q&A
- Confront trials by engaging with a physician to explore how manufacturers and regulators hope to maintain the trust of the public in a relatively novel class of medicines, faced with such potential for future variability, mistrust and misinformation
- Explore how the risks of extrapolation of indications can be minimised and the significance of this practice for the biosimilar industry
- Bring your own challenges to the forefront of the industry and discuss how to tackle prescriber objections